AI and Machine Learning: Streamlining and Focusing Clinical Trial Recruitment BioSpace

Artificial intelligence (AI) and machine learning are increasingly becoming a part of drug discovery and development beginning with identifying new compounds to structuring and designing clinical trials and targeting clinical trial populations. A recent example came out of Linköping University in Sweden. The investigators utilized an artificial neural network to create maps of biological networks based on how different genes or proteins interact with each other. The AI was then taught to find patterns of gene expression. And in mid-February, a drug developed using AI began testing in human clinical trials.